Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial (Q44212007)

30 November 2017

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial (English)

1 reference

30 November 2017

1 reference

1 reference

Romy Franken

3

0 references

Aeilko H Zwinderman

11

object named as

Aeilko H Zwinderman

1 reference

30 November 2017

1

Maarten Groenink

1 reference

30 November 2017

12

Barbara J M Mulder

1 reference

30 November 2017

Alexander W den Hartog

2

1 reference

30 November 2017

Teodora Radonic

4

1 reference

30 November 2017

Vivian de Waard

5

1 reference

30 November 2017

Janneke Timmermans

6

1 reference

30 November 2017

Arthur J Scholte

7

1 reference

30 November 2017

Maarten P van den Berg

8

1 reference

30 November 2017

Anje M Spijkerboer

9

1 reference

30 November 2017

Henk A Marquering

10

1 reference

30 November 2017

2 September 2013

1 reference

30 November 2017

European Heart Journal

1 reference

30 November 2017

34

1 reference

30 November 2017

45

1 reference

30 November 2017

3491-3500

1 reference

Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome

30 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Aortic root replacement in 372 Marfan patients: evolution of operative repair over 30 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Beyond the root: dilatation of the distal aorta in Marfan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

The molecular genetics of Marfan syndrome and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Marfan syndrome: from molecular pathogenesis to clinical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Angiotensin II type 1 receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Forest plots: trying to see the wood and the trees

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Determinants of echocardiographic aortic root size. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Inflammation aggravates disease severity in Marfan syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Aortic root asymmetry in marfan patients; evaluation by magnetic resonance imaging and comparison with standard echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Extracellular control of TGFbeta signalling in vascular development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

The distal aorta in the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHT334

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHT334

1 reference

30 November 2017

1 reference